Enterprise stent for the treatment of symptomatic intracranial atherosclerotic stenosis: an initial experience of 44 patients

Conclusion:
In this retrospective, single-center experience, undersized balloon angioplasty followed by Enterprise stent deployment appears technically feasible with a relatively low rate of complications for the treatment of complex symptomatic ICAS. Prospective, multicenter, randomized controlled trials against optimal medical management are warranted.

Source: BMC Neurology - October 8, 2015 Category: Neurology Authors: Zhengzhe FengGuoli DuanPing ZhangLei ChenYi XuBo HongWenyuan ZhaoJianmin LiuQinghai Huang Source Type: research